Catheter Ablation of Ventricular Fibrillation.
Autonomic nervous system
Catheter ablation
Purkinje fibers
Ventricular fibrillation
Journal
Cardiac electrophysiology clinics
ISSN: 1877-9190
Titre abrégé: Card Electrophysiol Clin
Pays: United States
ID NLM: 101549998
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
entrez:
17
11
2022
pubmed:
18
11
2022
medline:
22
11
2022
Statut:
ppublish
Résumé
Ventricular fibrillation (VF) is a common cause of sudden cardiac death (SCD) and is unfortunately without a cure. Current therapies focus on prevention of SCD, such as implantable cardioverter-defibrillator (ICD) implantation and anti-arrhythmic agents. Significant progress has been made in improving our understanding and ability to target the triggers of VF, via advanced mapping and ablation techniques, as well as with autonomic modulation. However, the critical substrate for VF maintenance remains incompletely defined. In this review, we discuss the evidence behind the basic mechanisms of VF and review the current role of catheter ablation in patients with VF.
Identifiants
pubmed: 36396189
pii: S1877-9182(22)00050-8
doi: 10.1016/j.ccep.2022.06.002
pii:
doi:
Substances chimiques
Anti-Arrhythmia Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
729-742Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Dr S.J. Asirvatham receives honoraria or speaker fees from Abiomed, Atricure, Biotronik, Blackwell Futura, Boston Scientific, Medtronic, Medtelligence, Spectranetics, St. Jude, and Zoll. Dr C.V. DeSimone is supported by the Dr Earl Wood, Career Development Benefactor award. Dr C.V. DeSimone and Dr S.J. Asirvatham have several patent submissions regarding novel mapping tools and ablation techniques for ventricular fibrillation. All other authors have no conflicts of interest to disclose relevant to the content of this article.